BDNF-overexpressing MSCs delivered by hydrogel in acute ischemic stroke treatment

BACKGROUND: Ischemic stroke treatment is a challenge worldwide. The efficacy and safety of mesenchymal stem cells (MSCs) for stroke have been confirmed. However, poor survival of MSCs in the ischemic environment limits the therapy efficacy. Changes in MSC status in the ischemic environment after tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Congxiao, Tian, Chuan, Cai, Duo, Jiang, Han, Zhang, Wei, Liu, Shifeng, Peng, Lijing, Hu, Xiaokun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843400/
https://www.ncbi.nlm.nih.gov/pubmed/36660688
http://dx.doi.org/10.21037/atm-22-5921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843400/
https://www.ncbi.nlm.nih.gov/pubmed/36660688
http://dx.doi.org/10.21037/atm-22-5921

Ejemplares similares